Phidippides cardiomyopathy: a review and case illustration

Justin E Trivax1, Peter A McCullough

  • 1Department of Cardiovascular Medicine, William Beaumont Hospital, Royal Oak, Michigan, USA.

Clinical Cardiology
|January 7, 2012
PubMed

Insights

Sudden cardiac death in endurance athletes may be linked to Phidippides cardiomyopathy. This condition, characterized by heart strain from prolonged exertion, can lead to arrhythmias and potentially fatal events.

Area of Science:

  • Cardiology
  • Sports Medicine
  • Exercise Physiology

Background:

  • Endurance sports like marathons are increasingly popular, raising concerns about exercise-induced sudden cardiac death.
  • Traditional causes of sudden cardiac death in athletes, such as hypertrophic cardiomyopathy, are often excluded.
  • Phidippides cardiomyopathy is an emerging consideration in unexplained sudden cardiac events following extreme exertion.

Observation:

  • Sustained high cardiac output during endurance events causes significant cardiac volume overload.
  • Approximately one-third of marathon runners exhibit right atrial and ventricular dilation.
  • Elevated cardiac troponin and natriuretic peptides are observed in affected athletes.

Findings:

  • A subset of endurance athletes develop cardiac fibrosis, a potential substrate for arrhythmias.
  • Phidippides cardiomyopathy presents a newly recognized risk for ventricular tachyarrhythmias and sudden death.
  • Cardiac magnetic resonance imaging is the preferred diagnostic tool for this condition.

Implications:

  • Recognizing Phidippides cardiomyopathy is crucial for evaluating sudden death in endurance athletes.
  • Further research is needed to understand the pathophysiology and long-term prognosis.
  • Screening and preventative strategies may be warranted for high-risk endurance athletes.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...